Sector consensus Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.88 USD | +1.08% |
|
-3.87% | +1.28% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 28.5 | +79.47% | 6 | ||||||
| 681.13 | +19.04% | 23 | ||||||
| 213.66 | +4.15% | 21 | ||||||
| 275.17 | +15.28% | 18 | ||||||
| 431.7 | +23.95% | 25 | ||||||
| 264,708.89 | +32.82% | 24 | ||||||
| 267.65 | +20.58% | 18 | ||||||
| 581.83 | -1.5% | 12 | ||||||
| 72.53 | +3.91% | 14 | ||||||
| 268.43 | +0.35% | 14 | ||||||
| 185.56 | +12.8% | 16 | ||||||
| 69.73 | -3.55% | 11 | ||||||
| 138.56 | +21.44% | 6 | ||||||
| 643.06 | +78.25% | 18 | ||||||
| 130.53 | -3.2% | 12 | ||||||
| 37.73 | -16.67% | 11 | ||||||
| 150.54 | +3.2% | 13 | ||||||
| 89.33 | +57.94% | 21 | ||||||
| 130.91 | +21.75% | 22 | ||||||
| 45.28 | +7.05% | 14 | ||||||
| Average | 13,457.54 | +18.85% | 16 | ||||||
| Weighted average by Cap. | 23,550.8 | +16.23% | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
